Global Pharmaceutical companies based in developed countries are increasingly turning to developing countries and emerging economies around the world for conducting clinical trials. Reduced costs combined with easy availability of patients with varied diseases makes developing countries favourite destinations for clinical research outsourcing.
regulanet®: Local representation for Global Regulatory Affairs
Pharmaceutical Licenesing and technology transfer